Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dipankar De

Showing results (111-120 of 297) with videos related to

Pageof 30
Sort By:
International Journal of Dermatology|August 2, 2024
Efficacy and safety of azathioprine versus mycophenolate mofetil in chronic actinic dermatitis in skin of color: results of a randomized controlled trialSanjeev Handa, Hitaishi Mehta, Anuradha Bishnoi, et al.
Frontiers in Pediatrics|December 14, 2023
Case report: Interleukin-17 targeted biological therapy in netherton syndromeRahul Mahajan, Shirin Bakshi, Anoop Kumar, et al.
JAMA Dermatology|January 1, 2016
Insulin Resistance and Metabolic Syndrome in Young Men With AcneMohit Nagpal, Dipankar De, Sanjeev Handa, et al.
Eye (London, England)|July 19, 2024
Oral and ocular findings in secondary syphilisAkshay Meena, Vinod Hanumanthu, Uday Tekchandani, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 16, 2019
Successful correction of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using full thickness skin graft in resource-poor settingsSatyaswarup Tripathy, Garima Dabas, Sanjeev Handa, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 15, 2023
Outcome of COVID-19 in patients with autoimmune bullous diseasesDipankar De, Raihan Ashraf, Hitaishi Mehta, et al.
Skinmed|January 5, 2008
An unusual presentation of mucous membrane pemphigoidDipankar De, Sunil Dogra, Uma Nahar Saikia, et al.
Skinmed|March 11, 2008
Bullous eruption in a patient infected with the human immunodeficiency virusDipankar De, Amrinder J Kanwar, Bishan D Radotra, et al.
Clinical and Experimental Dermatology|April 6, 2022
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigusNamrata Singh, Sanjeev Handa, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|September 19, 2025
Treatment with Rituximab is associated with significantly improved cutaneous sclerosis: real-world observations in an Indian cohortSanjeev Handa, Anubha Dev, Anuradha Bishnoi, et al.
Pageof 30

Showing results (111-120 of 297) with videos related to

Sort By:
Pageof 30
International Journal of Dermatology|August 2, 2024
Efficacy and safety of azathioprine versus mycophenolate mofetil in chronic actinic dermatitis in skin of color: results of a randomized controlled trialSanjeev Handa, Hitaishi Mehta, Anuradha Bishnoi, et al.
Frontiers in Pediatrics|December 14, 2023
Case report: Interleukin-17 targeted biological therapy in netherton syndromeRahul Mahajan, Shirin Bakshi, Anoop Kumar, et al.
JAMA Dermatology|January 1, 2016
Insulin Resistance and Metabolic Syndrome in Young Men With AcneMohit Nagpal, Dipankar De, Sanjeev Handa, et al.
Eye (London, England)|July 19, 2024
Oral and ocular findings in secondary syphilisAkshay Meena, Vinod Hanumanthu, Uday Tekchandani, et al.
Indian Journal of Dermatology, Venereology and Leprology|May 16, 2019
Successful correction of pseudosyndactyly in recessive dystrophic epidermolysis bullosa using full thickness skin graft in resource-poor settingsSatyaswarup Tripathy, Garima Dabas, Sanjeev Handa, et al.
Indian Journal of Dermatology, Venereology and Leprology|June 15, 2023
Outcome of COVID-19 in patients with autoimmune bullous diseasesDipankar De, Raihan Ashraf, Hitaishi Mehta, et al.
Skinmed|January 5, 2008
An unusual presentation of mucous membrane pemphigoidDipankar De, Sunil Dogra, Uma Nahar Saikia, et al.
Skinmed|March 11, 2008
Bullous eruption in a patient infected with the human immunodeficiency virusDipankar De, Amrinder J Kanwar, Bishan D Radotra, et al.
Clinical and Experimental Dermatology|April 6, 2022
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigusNamrata Singh, Sanjeev Handa, Rahul Mahajan, et al.
Clinical and Experimental Dermatology|September 19, 2025
Treatment with Rituximab is associated with significantly improved cutaneous sclerosis: real-world observations in an Indian cohortSanjeev Handa, Anubha Dev, Anuradha Bishnoi, et al.
Pageof 30